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Abstract
Background: The entire gastrointestinal tract is protected by a mucous layer, which contains complex glycoproteins called
mucins. MUC2 is one such mucin that protects the colonic mucosa from invading microbes. The initial interaction between
microbes and mucins is an important step for microbial pathogenesis. Hence, it was of interest to investigate the
relationship between host (mucin) and pathogen interaction, including Shigella induced expression of MUC2 and IL-1b
during shigellosis.
Methods: The mucin-Shigella interaction was revealed by an in vitro mucin-binding assay. Invasion of Shigella dysenteriae
into HT-29 cells was analyzed by Transmission electron microscopy. Shigella induced mucin and IL-1b expression were
analyzed by RT-PCR and Immunofluorescence.
Results: The clinical isolates of Shigella were found to be virulent by a congo-red binding assay. The in vitro mucin-binding
assay revealed both Shigella dysenteriae and Shigella flexneri have binding affinity in the increasing order of: guinea pig small
intestinal mucin,guinea pig colonic mucin, Human colonic mucin. Invasion of Shigella dysenteriae into HT-29 cells occurs
within 2 hours. Interestingly, in Shigella dysenteriae infected conditions, significant increases in mRNA expression of MUC2
and IL-1b were observed in a time dependent manner. Further, immunofluorescence analysis of MUC2 shows more positive
cells in Shigella dysenteriae treated cells than untreated cells.
Conclusions: Our study concludes that the Shigella species specifically binds to guinea pig colonic mucin, but not to
guinea pig small intestinal mucin. The guinea pig colonic mucin showed a greater binding parameter (R), and more
saturable binding, suggesting the presence of a finite number of receptor binding sites in the colonic mucin of the host.
In addition, modification of mucins with TFMS and sodium metaperiodate significantly reduced mucin-bacterial
binding; suggesting that the mucin-Shigella interaction occurs through carbohydrate epitopes on the mucin
backbones. Overproduction of MUC2 may alter adherence and invasion of Shigella dysenteriae into human colonic
epithelial cells.
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Introduction
Mucosal surfaces employ a number of protective strategies to
defend against noxious substances and pathogens found within
the intestinal lumen. The mucosal surface contains mucins,
which are complex glycoproteins synthesized and secreted by
epithelial cells of various organs to lubricate and protect luminal
surfaces of the human body [1]. However, excessive mucin
secretion is a hallmark of the pathogenesis of several diseases,
including infectious diseasess u c ha si n f l a m m a t o r yb o w e l
diseases and Shigellosis [2–4]. The exact role of mucins in gut
protection is not completely understood. Although adherence is
recognized as an important initial step in other bacterial
infections [5–7], relatively little information is available on the
mechanisms of attachment of Shigellae to cells on the mucosal
surface. A specific site on the host may be involved in the
binding of pathogenic bacteria; for example, Hemophillus
influenzae, a respiratory pathogen, specifically binds to respira-
tory mucins but does not bind or cause disease in the intestinal
tract. Also, enterotoxigenic E. coli infects and causes diseases
only in the intestinal tract [8,9].
Infection of epithelial cells with bacterial pathogens can induce
the excessive production of intracellular adhesion molecules
(ICAM-1) and mucins (MUC2 and MUC5AC) through the
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27046activation of TNFa and Interleukin-1 secretion [10–14]. In vivo
inoculation of Shigella species altered the expression of MUC2 and
MUC5AC in rabbit intestinal epithelial cells, through production
of the inflammatory cytokine TNFa [4]. Proinflammatory
cytokines such as TNFa and IL-1b can induce the production of
MUC2 and MUC5AC in human intestinal and airway epithelial
cells [15]. Shigella flexneri stimulates differential mucin gene
expression in human colon cancer cells, thereby reducing the
production of inflammatory cytokines [16]. The production of
different mucins with different levels of expression might involve
protection of host epithelium from Shigella flexneri induced
inflammation [16].
Shigellae can induce acute intestinal inflammation through the
production of many inflammatory cytokines and chemokines from
infected epithelial cells [17]. However, the exact relationships
between bacterial infection and types of mucin gene expression
under shigellosis have yet to be examined. The present study
aimed to examine the interaction between Shigella species and
intestinal mucin in an attempt to identify region-specific initial
binding sites for Shigella species. Furthermore, to evaluate the
involvement of inflammatory cytokines in the hyper production of
MUC2 during shigellosis.
Methods
Bacterial strains, media and growth conditions
Clinical isolates of Shigella dysenteriae (S. dysenteriae) and Shigella
flexneri (S. flexneri) obtained from the Department of Medical
Microbiology, Christian Medical College, Vellore, India, were
routinely grown in Luria-Bertani (LB) broth or Tryptic soy broth
(Himedia, Mumbai, India) at 37uC.
Isolation and purification of Guinea pig intestinal mucin
The mucin glycoprotein was isolated from Guinea pig as
described previously [18–20]. Briefly, Male Duncan Hartley
strains of guinea pigs were fasted for 48 h and sacrificed by
cervical dislocation. The intestine was removed from the duodenal
portion after the stomach to the colon, and immediately washed in
ice-cold sterile PBS containing protease inhibitors [5 mM EDTA,
1 mM PMSF and 10 mM N-ethyl maleimide (NEM)]. The
mucosal surface was gently scraped using a rubber spatula, taking
care not to damage the underlying epithelium. The mucus
scrapings were lyophilized and redissolved in 50 mM Tris-HCl
(pH 8.0) containing 4 M guanidium hydrochloride, 0.02% sodium
azide, 1 mM PMSF, 5 mM EDTA and 2 mM N-ethyl maleimide,
by stirring overnight at 4uC. The solution was centrifuged at
10,0006g for 20 min at 4uC to remove debris and insoluble
material. The mucins were partially purified by Sepharose CL-4B
column chromatography. The fractions showing positive reaction
with Morgan and Elson assay reagent were pooled, dialyzed and
lyophilized. The partially purified mucin samples were stored at
220uC.
Modification of mucins
Partially purified mucin from Guinea pig small intestine and
colon was subjected to various physicochemical treatments and
was used for in vitro binding studies.
Tetramethyl urea (TMU) treatment
Treatment of bacteria with Tetra methyl urea was carried out as
described in [21]. Briefly, Bacterial cells were incubated with
0.5 M TMU (final concentration) for 1 h at 37uC. Bacteria was
harvested by centrifugation, washed to remove excess TMU, and
then added to wells coated with mucin.
Oxidation
50 mg of mucin (dry weight), dissolved in 3 ml of PBS (pH 7.4),
was treated with sodium metaperiodate (3.1–100 mM) at 4uC for
1 hr in the dark for nonspecific oxidation of sugar moieties.
Oxidized mucin was then dialyzed against distilled water for 24 h
and used for binding assays.
Boiling
Guinea pig colonic mucin (10 mg/ml) was heated in a water
bath at 100uC/10 min and cooled to room temperature. These
boiled mucins were used for binding assays.
Partial deglycosylation
Partial deglycosylation of mucin was done as described
previously [22]. Guinea pig colonic mucin (,25 mg dry weight)
was treated with 1 ml of TFMS-Anisole reagent at 0uC, on ice.
The reaction was terminated by adding a two-fold excess of ether;
precooled to 0uC, drop wise, avoiding bubbling due to exothermic
heat. The upper layer of ether was removed by centrifugation at
1500 rpm/10 min. the aqueous phase was dialyzed against
distilled water to remove traces of ether and pyridinium salts.
The dialysate was lyophilized to be used as partially deglycosylated
mucin for binding studies.
Enzyme-linked immunosorbent assay
This assay was done as described in [23]. Briefly, microtitre
plates (Nunc, immunomodule Maxisorp Denmark) were coated
with serially diluted mucin (150 mg mucin protein/well to 1 mg
mucin protein/well) in 0.05 M Carbonate buffer (pH 9.6) and
incubated overnight at 4uC. The unbound mucin was removed by
three washes with PBS-T (0.05%Tween 20). Residual binding sites
were blocked with PBS-2%BSA and incubated at 37uC for 1 h.
After removing unbound BSA by three washes with PBS-T, 100 ml
containing different concentrations of (cfu/ml) bacteria were
added to each well and incubated at 37uC for 1 h. The unbound
bacteria were removed by washing three times with PBS-T. 100 ml
of mouse monoclonal antibody against Shigella species (E-Merck,
Mumbai, India) (1:1000 in PBS-1%BSA) was added to each well
and incubated at 37uC for 1 h. The unbound antibody was
removed by washing three times with PBS-T. 100 ml of Rabbit
anti mouse HRP conjugated secondary antibody (1:2000 in PBS-
1%BSA) was added to each well and incubated at 37uC for 1 h.
The unbound antibody was removed by washing three times with
PBS-T. Then, the wells were incubated in the dark with 100 mlo f
substrate (TMB/H2O2) for 15 min. 100 mlo f1MH 2SO4 was
added to arrest the reaction. The colour developed was measured
at 450 nm in a Perkin-Elmer micro plate reader. All experiments
were done in triplicate and repeated thrice. Specific binding to
mucin (binding parameter ‘R’) was calculated by subtracting the
value of bacteria bound to BSA from the values of bacteria bound
to mucin. A value of .2 indicates specific binding. Pig gastric
mucin was (Sigma, USA) used as a negative control.
Virulence assay
The virulence nature of Shigella species were assessed by Congo-
red dye binding assay and the procedure was followed as described
previously [24]. Briefly, bacterial strains were grown in Congo red
(0.01%) supplemented Tryptic soy broth containing 0.6% yeast
extract and 1.5% agar at 37uC for 18 h.
Cell culture conditions
HT 29 human colon tumor cell line was obtained from National
Centre for Cell Science, Pune, India. HT 29 cells were grown in
Shigella Induced Mucin Gene Expression
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Germany), supplemented with 10% Fetal bovine serum (FBS)
(Sigma, USA), 100 units/ml Penicillin, 100 mg/ml Streptomycin
and 10–20 mg/ml fungisone (Himedia, India).
Infection of HT 29 cells with Shigella dysenteriae
HT 29 cells were seeded into 6 well Costar tissue culture plates
at a density of 2610
5 cells/ml in volumes of 2 ml per well. At this
seeding density, monolayers were sub-confluent (80–90%) at the
time of the experiment. Bacteria were grown overnight at 37uCi n
LB medium and pelleted by centrifugation at 12,000 g for 5 min
at 4uC. The cell pellets were washed with PBS (pH 7.4) twice and
suspended in antibiotic-free DMEM. Bacteria at 100 cells per
epithelial cell (100:1 ratio) were used to infect for 2 h to allow
bacterial entry to occur. Monolayers were washed twice to remove
extracellular bacteria and the cultures were incubated for different
time intervals in the presence of 50 mg/ml of gentamicin to kill the
remaining extracellular bacteria.
Investigation of bacterial adhesion and invasion of HT 29
cells by Transmission Electron Microscopy (TEM)
Infection of epithelial cells with Shigella dysenteriae was done as
described above. The infection was stopped at 1 h and 2 h time
interval for adherence and invasion analysis by TEM as described
previously [25]. Infected epithelial monolayers on culture dishes
were fixed in 3% (v/v) glutaraldehyde (in 0.1 M sodium
cacodylate buffer, pH 7.4) for 2 h. All the samples were washed
in PBS and post fixed in 1% osmium tetroxide for 1 h before
dehydration in ethanol and embedded in Epon resin, according to
standard procedures. Ultrathin sections (60–100 nm) were cut,
and uranyl acetate and lead citrate stains were applied prior to
examination and photography with a Philips 201C (Netherland)
transmission electron microscope.
Immunofluorescence studies for mucin gene expression
HT 29 cells infected with Shigella dysenteriae were grown for 2 h
on cover slips for complete and tight attachment and washed with
DMEM in the presence of 50 mg/ml of gentamicin to kill the
remaining extracellular bacteria. The infected monolayers were
incubated for 0, 1, 3, 6 and 9 h. The infected monolayers were
washed with PBS for 5 min and subsequently the cells were
permeablized with 0.1% Triton X-100 in PBS for 5 min on ice.
Cells were washed and the non-specific binding sites were blocked
with PBS containing 0.1% BSA for 10 min at room temperature
before antibody incubation. Cells were washed twice with PBS/
BSA and incubated with mouse monoclonal antibody for MUC2
at 1:50 dilution for 1 h at room temperature (E-Merck, Mumbai,
India). After the incubation period, monolayers were washed twice
with PBS and incubated with secondary antibody (anti-mouse
FITC) for 1 h in the dark. After the incubation period, monolayers
were washed twice with PBS and the cover slips were mounted
with 90% glycerol in PBS. The cells were screened under a
fluorescence microscope (Carl Zesis, Germany) with 206magni-
fications.
RT-PCR analysis of Mucin and IL-1b gene expression
Total RNA was extracted from control cells, cells preincubated
with actinomycin D (1 mg/ml) for 30 min and Shigella dysenteriae
infected HT 29 cells, using Trizol reagent (Sigma- Aldrich, USA).
For cDNA synthesis, 2 mg of total RNA were used as the template
in a 20 ml RT reaction mixture by using Reverse-iT
TM first strand
synthesis kit (ABgene, UK). 100 ng of cDNA template in a total
volume of 25 ml was used for reverse transcription. PCR analysis of
mRNAs of MUC2, IL-1b and b-actin were carried out by using
forward and reverse primers listed below; for MUC2 gene, 59-
ACAACTACTCCTCTACCTCCA-39 and 59-GTTGATCT
CGTAGTTGAGGCA-39; for IL-1b gene, 59-AAACAGAT-
GAAGTGCTCCTTCCAGG-39 and 59-TGGAGAACACCA
CTTGTTGCTCCA-39; for b-actin gene, 59-GTGGGGCG
CCCCAGGCACCA-39 and 59-CTCCTTAATGTCCGGAC-
GATTC-39. The PCR reaction conditions for all the genes were
as follows: 94uC for 2 min (1 cycle); 94uC for 30 s, 58uC for 30 s,
and 72uC for 1 min (30 cycles); and 72uC for 5 min. The PCR
products were subjected to electrophoresis (130 V, constant-
voltage field) on a 1% agarose gel equilibrated in Tris-borate
electrophoresis buffer containing ethidium bromide (1 mg/ml).
Gels were photographed under UV light. The band intensity was
measured by using Image J program.
Results
Virulent nature of Shigella
The virulent nature of the Shigella species was analyzed by in vitro
Congo-red binding assay, appearance of orange/pink color
colonies of S. dysenteriae (Fig. 1a) and S. flexneri (Fig. 1b) suggest
that these species are highly virulent when compared to pale white
Figure 1. Congo-red binding assay. Shigella species were grown in Congo-red agar plate. Orange-pink colour colonies of Shigella dysenteriae (a)
and Shigella flexneri (b) indicate the highly virulent nature and plasmid DNA cured non-virulent Shigella flexneri (c) shows white colour colonies.
doi:10.1371/journal.pone.0027046.g001
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flexneri (Fig. 1c).
Bacterial binding to native mucin
The binding of Shigella dysenteriae and Shigella flexneri to human
colonic mucin and guinea pig colonic mucin was concentration
dependent and saturable. Human colonic mucin protein (12.5 mg
per well) and Guinea pig colonic mucin protein (50 mg per well)
gave sufficient receptor sites (Fig. 2a and 3a). Bacterial
concentrations of 1.6610
7 cfu/well for S. dysenteriae and
1.5610
7 cfu/well for S. flexneri gave maximal binding to mucins,
while bacterial concentrations higher than 1.5610
7 cfu/well, the
receptor mucin was saturated (Fig. 2b and 3b). The guinea pig
small intestinal mucin and Pig gastric mucin concentration of
Figure 2. Binding of Shigella dysenteriae to mucins. a. Binding of Shigella dysenteriae to varying concentrations of different mucins. b. Binding of
different amount of Shigella dysenteriae to human and guinea pig mucins. Each value is the mean of triplicate determinations. The assay was carried
out as described in materials and methods.
doi:10.1371/journal.pone.0027046.g002
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bacteria (1.5610
7 cfu/well). The number and affinity of binding
sites for S. dysenteriae and S. flexneri was found to be increasing in the
order of guinea pig small intestinal mucin (GPSIM) , guinea pig
colonic mucin (GPCM) , human colonic mucin (HCM). The
binding results suggest a very high degree of site specificity and
Figure 3. Binding of Shigella flexneri to mucins. a. Binding of Shigella flexneri to varying concentration of different mucins. b. Binding of different
amount of Shigella flexneri to human and guinea pig mucins. Each value is the mean of triplicate determinations.
doi:10.1371/journal.pone.0027046.g003
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dysenteriae and S. flexneri to mucins from different species. None of
the clinical isolates bound to unrelated mucin, such as Pig gastric
mucin. The human colonic mucin was used as a positive control.
Bacterial binding to modified mucin
The possibility of non-specific hydrophobic interactions medi-
ating the binding to BSA and mucin was investigated by using an
effective hydrophobic interaction inhibitor, Tetramethyl urea.
Bacterial binding to small intestinal mucin of guinea pig and BSA
were diminished at 0.5 M concentrations of TMU (data not
shown). However, TMU, did not have any significant effect on S.
dysenteriae and S. flexneri binding to guinea pig colonic mucin. The
adherence of S. dysenteriae and S. flexneri to boiled mucin was
significantly higher than the untreated native mucin (Fig. 4a and
4b), whereas, treatments of mucins with periodate and TFMS
showed significantly reduced binding to S. dysenteriae and S. flexneri
(Fig. 4a and 4b). Guinea pig colonic mucins that were treated with
varying concentrations of periodate show markedly decreased
binding to S. dysenteriae and S. flexneri, in a concentration dependent
manner (Fig. 5a and 5b).
Adhesion and invasion of Shigella dysenteriae to HT29
cells by TEM
The control HT 29 cells showed intact nuclei, cytoplasm and
other cell organelles (Fig. 6a). HT 29 cells infected with Shigella
dysenteriae (1–2 h) showed the intimate contact between the
bacterium and host cell membrane (Fig. 6b). Also, endocytic
processes, formation of pseudopod projections and phagocytosed
bacteria were located in the vacuoles of Shigella dysenteriae infected
HT 29 cells (Fig. 6c).
Expression of MUC2 and IL-1b gene in HT 29 cells by RT-
PCR
MUC2 (348 bp) and IL-1b (388 bp) gene expressions were
observed at basal levels in control cells, whereas, in the S. dysenteriae
infected conditions, higher levels of MUC2 (,4–5 fold for 9 h) and
IL-1b (25 fold for 9 h) mRNA were observed in a time dependent
manner (Fig. 7). Prior to S. dysenteriae infection, HT 29 cells were
pre-incubated with actinomycin D (1 mg/ml) for 30 min, which
showed lessIL-1b expression with increasing time of incubation
(Fig. 7). Amplification of b-actin (131 bp) was used as an internal
control.
Immunofluorescence analysis of MUC 2 expression
HT 29 cells were infected with Shigella dysenteriae for 2 hours and
allowed to incubate at different time intervals (0–9 hours) before
analysis of MUC2 expression. Approximately 300 cells were
positive with green fluorescence of MUC2 expression. Control HT
29 cells showed normal basal level expression of MUC2 (+)u pt o
9 h of incubation (Fig. 8a), whereas, HT 29 cells infected with
Shigella dysenteriae showed increased expression of MUC 2 in a time
dependent manner (+,1h ;++,3h ;+++, for 6 and 9 h) (Fig. 8b–e).
Discussion
The pathogenesis of most of enteropathogens occurs by
successful colonization, adherence and invasion on the epithelial
cells in the gastrointestinal tract. Previous studies suggest that the
invasion of enteropathogens into intestinal epithelial cells is an
important step in virulence mechanism of Shigella pathogenesis
[26]. During the course of infection, bacterial colonization occurs
by the interaction of their adhesin(s) to cognate receptors available
on epithelial cells or the extracellular matrix [27]. Reports are
available on the mechanism of initial attachment by various
pathogens like Vibrio cholerae [28], Salmonella typhimurium [29], and
Yersinia enterocolitica [30] to the host mucus layer and intestinal
epithelial cells.
Earlier work on the in vitro binding of S. flexneri [31–32] and
enteropathogenic E.coli [33] to intestinal epithelial cells showed
that the adherence of the bacterium is due to the presence of
plasmid DNA (,140 MDa) encoded factors. These are known as
Invasive plasmid antigens (Ipa). IpaA, IpaB, IpaC, IpaD, IcsA and
IcsB, and are essential virulence factors for attachment, invasion
and intracellular spread [34–36]. The virulent nature of S.
dysenteriae and S. flexneri were determined by Congo red binding
on agar plate, where highly virulent Shigella dysenteriae showed
orange/pink color colonies, suggesting that plasmid DNA and its
associated virulence factors are intact, whereas, white color
colonies indicate non-virulent bacteria [24].
The mucosa, containing mucin glycoprotein, is thought to have
dual roles, one in protecting the host from pathogens, as well as
being able to facilitate the preliminary attachment by the
pathogens [37]. On the other hand there are reports emphasizing
role of mucin glycoproteins in pathogenesis of Helicobacter pylori
induced gastric carcinoma [38] and Pseudomonas aeruginosa infection
in cystic fibrosis (CF) patients [39]. To determine whether the
mucin layer of the gastrointestinal tract acts as a receptor for
Shigella species for firm attachment, and if so, is it the protein core
or the oligosaccharide structures, which is involved. The virulent S.
dysenteriae and S. flexneri showed preferential binding to human
colonic mucin compared with all other mucins. It was clearly
evident that the number and affinity of binding sites for Shigella
dysenteriae and Shigella flexneri were found to be increasing in order of
guinea pig small intestinal mucin ,guinea pig colonic mucin ,
Table 1. The binding parameters of S. dysenteriae and S. flexneri to mucins from different species.
Mucin Binding parameter ‘R’
S. dysenteriae S. flexneri
Human colon mucin 7.45160.326–1.05560.321 6.76960.289–0.85460.19
Guinea pig colon mucin 3.35760.138–0.75360.228 2.93760.129–0.68060.184
Guinea pig small intestinal mucin 1.41560.249–0.69360.182 1.22860.162–0.74660.101
PGM porcine type II mucin 0.91860.18–0.66260.182 0.86860.167–0.33260.046
Microtiter plates were coated with a fixed concentration of mucin (12.5 mg for human; 50 mg for guinea pig). 100 ml of bacteria (,1610
10 cfu/well) was added. The
values are the mean 6 S.D triplicate determinations of one representative experiment. (PGM, Pig gastric mucin).
doi:10.1371/journal.pone.0027046.t001
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degree of site specificity and species specificity of Shigella species.
Similar binding patterns were observed in human colonic mucins
with Shigella dysenteriae binding [40]. It provides the evidence that
the Shigella species is able to bind to human colonic mucin with
high affinity as compared with guinea pig colonic mucin.
Various pathogens have their own tissue tropism. Staphylococcus
has a binding affinity to ferret nasal and bovine submaxillary
mucin [41]. The peptide backbone of the mucin glycoprotein is
unique in some aspects, and shows much more uniformity in
profile than do oligosaccharide chains [42]. Diversity of mucin-
oligosaccharide structure calls for selective affinity of organisms to
mucins of different sources. The Guinea pig colonic mucin
(GPCM) may harbor more receptor sites than the others, but less
than human colonic mucin receptor sites.
Binding of Shigella to guinea pig small intestinal mucin and BSA
via the influence of hydrophobic interaction was ruled out, as there
was no influence on S. dysenteriae and S. flexneri binding to TMU
treated guinea pig colonic mucin. Thus, the receptor-mediated
binding of Shigella to GPCM is evident. Further, Mucin pretreated
with sodium metaperiodate showed decreased binding, which may
be due to oxidation of vicinal hydroxyl groups on carbohydrate
moiety [43]. Partial deglycosylation of carbohydrate moieties with
TFMS resulted in decreased binding, indicating carbohydrate
chains were essential components of the binding sites of GPCM
receptor for Shigella species. Similar results were identified in many
pathogens [44–46].
Denaturation of mucins by boiling at 100uC resulted in
significant increases the pathogen binding, suggesting that
dissociation of the polymer into monomeric glycoproteins exposes
a number of new receptor sites for the bacteria. Similar
observations were reported earlier with Yersinia enterocolitica [47].
It is very clear from this study that S. dysenteriae and S. flexneri bind
specifically to the carbohydrate portion of Guinea pig colonic
Figure 5. Adherence of S. dysenteriae and S. flexneri to sodium
metaperiodate treated mucins. S. dysenteriae (a) and S. flexneri (b)
showed significantly reduced adherence to sodium metaperiodate
treated mucins in a concentration dependent manner when compared
with untreated mucins. Each value is the mean of triplicate
determinations. A p value of less than .05 is considered to be
significant. Each comparison was made on bacterial adherence to
untreated versus treated mucins.
doi:10.1371/journal.pone.0027046.g005
Figure 4. Adherence of S. dysenteriae and S. flexneri to modified
mucins. S. dysenteriae (a) and S. flexneri (b) showed significantly
reduced adherence to sodium metaperiodate and TFMS treated mucins.
Whereas, mucins treated with TMU did not affect the bacterial binding
to GPCM. Boiling of mucins at 100uC for 10 min significantly increased
bacterial binding to GPCM. Each value is the mean of triplicate
determinations. A p value of less than 0.05 is considered to be
significant. Each comparison was made on bacterial adherence to
untreated versus treated mucins.
doi:10.1371/journal.pone.0027046.g004
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adherence and establishment of colonization of Shigella species.
The pathogenesis of Shigella species is mostly contributed by its
ability to invade the colonic mucosal epithelium [48]. It still
remains unclear whether the initial binding to the colonic mucin
would block or facilitate further binding and invasion of Shigella to
the underlying epithelial cells. Our study shows that most of the
bacterial cells entered into the HT 29 cells within 2 h of infection.
This invasion was confirmed by transmission electron microscopy
and it revealed the occurrence of bacterial adherence, bacteria -
induced pseudopod formation, invasion and accumulation in the
host cell cytoplasm. This study confirms the previous findings on
the invasive nature of Shigella species [48].
The relationship between bacterial infection and over expres-
sion of MUC2 and MUC5AC were emphasized especially in the
respiratory tract and middle ear epithelial cells [11,49–52].
Pseudomonas aeruginosa, a common Cystic fibrosis pathogen,
activates MUC2 mucin gene transcription by activation of a
Src-dependent Ras-MEK1/2-ERK1/2-pp90rsk-NF-kB pathway
[53]. Our Previous findings on rabbit ileal loop infection assay, in
vivo, with Shigella species showed up-regulation of MUC2,
MUC5AC and proinflammatory cytokine expressions [4]. The
present study shows that the expression of MUC2 transcript was
increased in a time - dependent manner in HT 29 cells infected
with Shigella dysenteriae. Further, its expression at protein level was
confirmed by immunostaining infected cells with MUC2 antibody.
The results revealed a time dependent increase of MUC2
expression. This study suggests that the expression of MUC2
was up-regulated at both transcriptional and translational levels.
These observations suggest that mucins are normally expressed in
human colonic epithelial cells, but under infectious conditions, are
upregulated, and may be involved in the mucociliary clearance of
enteric pathogens.
The expression of the proinflammatory cytokine IL-1b was
observed in Shigella infected macrophages [54]. The major
function of IL-1b is to recruit the inflammatory polymorphonu-
clear cells that infiltrate to the infected site and destabilize the
epithelium [55]. In addition to inflammation, it can also induce
the expression of MUC2 and MUC5AC mRNA in intestinal and
airway epithelial cancer cell lines [56–58]. Similar findings were
also observed with IL-4, IL-13 and IL-19 on induced mucin gene
expression in various epithelial cells [53,59–61]. The present study
also confirms the previous reports by showing a time dependent
increase in IL-1b and MUC2 expression during S. dysenteriae
infection of human epithelial cells. Further, IL-1b expression was
depleted upon treatment with actinomycin D, which provided
additional evidence that S. dysenteriae could induce the expression of
IL-1b in infected host cells. The over expression of MUC2 may be
due to increased expression of IL-1b, consistent with the examples
stated above. Further studies are required to identify the
mechanism of mucin gene expression and its role in protection
against Shigellosis.
Figure 6. Shigella dysenteriae adherence and invasion of human
epithelial cells by Transmission Electron Microscopy. After 1 h
and 2 h of infection, cells were fixed and processed for Transmission
Electron Microscopy analysis as described in materials and methods.
Control cells showed intact nuclei and other cell organelles (a). 1 h of
infection of HT 29 cells with Shigellae showed the adherence and
pseudopod projection formation (b). Endocytic processes and phago-
cytosis of bacteria was seen in the vacuoles of HT 29 cells at the end of
2 h infection (c). The scale bars indicate 1 mm. [M – Mucin; A –
Adherence; P – Pseudopod formation; I - Invasion].
doi:10.1371/journal.pone.0027046.g006
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PLoS ONE | www.plosone.org 8 November 2011 | Volume 6 | Issue 11 | e27046Figure 7. RT-PCR analysis of MUC2 and IL-1b expression in Shigella dysenteriae infected HT 29 cells. HT 29 cells were infected with
Shigella dysenteriae for different time intervals. After infection, mRNA was isolated for MUC2 and IL-1b gene expression analysis as described in
methods. HT-29 control cells showed basal level expression of both MUC2 and IL-1b. Whereas, higher level (intensity) expression of both MUC2 (,4–5
fold higher for 9 h) and IL-1b (25 fold higher for 9 h) were seen in a time dependent manner upon HT-29 cells infected with S. dysenteriae. HT 29 cells
pre-incubated with Actinomycin D (1 mg/ml) for 30 min, prior to S. dysenteriae infection, showed lower level of expression of IL-1b. The band intensity
was measured by using image J program. Amplification of b-actin was used as an internal control.
doi:10.1371/journal.pone.0027046.g007
Figure 8. Immunofluorescence analysis of MUC2 expression in Shigella dysenteriae infected HT 29 cells. HT 29 cells were infected with
Shigella dysenteriae in the ratio of 100 bacteria per epithelial cell. Cell monolayers were washed twice to remove extracellular bacteria and the cultures
were incubated for different time intervals (0–9 h) in the presence of 50 mg/ml of gentamicin for mucin gene expression analysis. The percentage (%)
of cells which expressed MUC2 was classified as follows: 2, none; +, light or weak; ++, moderate; +++, intense. In each experiment 300 cells were
counted. Control cells, up to 9 h showed a weak signal (+) and for 1 h incubation with S. dysenteriae (+); for 3 h, (++); for 6 h, (+++); and for 9 h
incubation (+++). (206magnification).
doi:10.1371/journal.pone.0027046.g008
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